Infimmune is dedicated to discovering and advancing early-stage assets that hold the promise of fundamentally transforming the lives of individuals affected by autoimmune diseases. Founded by clinicians aware of a significant unmet need for genuinely disease-modifying treatments, we aim to intervene in the early stages of pathogenesis and make a meaningful impact on patients’ lives.